Clinical utilization of four-factor prothrombin complex concentrate: a retrospective single center study

OBJECTIVE: Four-factor prothrombin complex concentrate (4F-PCC) was approved by the US Food and Drug Administration in 2013 for management of severely bleeding patients on warfarin therapy. We describe use of 4F-PCC at a large, suburban academic center. METHODS: We retrospectively reviewed all patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Naeem, Zaina, Allan, Salsabeel, Hernandez, Aneury, Galanakis, Dennis K, Singer, Adam J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Emergency Medicine 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273669/
https://www.ncbi.nlm.nih.gov/pubmed/34237811
http://dx.doi.org/10.15441/ceem.20.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273669/
https://www.ncbi.nlm.nih.gov/pubmed/34237811
http://dx.doi.org/10.15441/ceem.20.017

Ejemplares similares